Submaximal Dosing Plays Important Role in Minimizing Proteinuria

In a Pharmacy Times® interview, Chi Chu, MD, an assistant professor in the division of nephrology at the University of California San Francisco, spoke about his 2021 ASN Kidney Week presentation on the submaximal dose of angiotensin converting enzyme (ACE) inhibitor and angiotensin II receptor blockers (ARB) for individuals with proteinuria.

He discussed why submaximal dosing is important in minimizing proteinuria and chronic kidney disease.